Literature DB >> 11719411

Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study.

H U Irgens1, L Reisaeter, L M Irgens, R T Lie.   

Abstract

OBJECTIVE: To assess whether mothers and fathers have a higher long term risk of death, particularly from cardiovascular disease and cancer, after the mother has had pre-eclampsia.
DESIGN: Population based cohort study of registry data.
SUBJECTS: Mothers and fathers of all 626 272 births that were the mothers' first deliveries, recorded in the Norwegian medical birth registry from 1967 to 1992. Parents were divided into two cohorts based on whether the mother had pre-eclampsia during the pregnancy. Subjects were also stratified by whether the birth was term or preterm, given that pre-eclampsia might be more severe in preterm pregnancies. MAIN OUTCOME MEASURES: Total mortality and mortality from cardiovascular causes, cancer, and stroke from 1967 to 1992, from data from the Norwegian registry of causes of death.
RESULTS: Women who had pre-eclampsia had a 1.2-fold higher long term risk of death (95% confidence interval 1.02 to 1.37) than women who did not have pre-eclampsia. The risk in women with pre-eclampsia and a preterm delivery was 2.71-fold higher (1.99 to 3.68) than in women who did not have pre-eclampsia and whose pregnancies went to term. In particular, the risk of death from cardiovascular causes among women with pre-eclampsia and a preterm delivery was 8.12-fold higher (4.31 to 15.33). However, these women had a 0.36-fold (not significant) decreased risk of cancer. The long term risk of death was no higher among the fathers of the pre-eclamptic pregnancies than the fathers of pregnancies in which pre-eclampsia did not occur.
CONCLUSIONS: Genetic factors that increase the risk of cardiovascular disease may also be linked to pre-eclampsia. A possible genetic contribution from fathers to the risk of pre-eclampsia was not reflected in increased risks of death from cardiovascular causes or cancer among fathers.

Entities:  

Mesh:

Year:  2001        PMID: 11719411      PMCID: PMC59993          DOI: 10.1136/bmj.323.7323.1213

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  24 in total

1.  Familial occurrence of preeclampsia.

Authors:  I Mogren; U Högberg; A Winkvist; H Stenlund
Journal:  Epidemiology       Date:  1999-09       Impact factor: 4.822

2.  Preterm birth and maternal smoking: risks related to gestational age and onset of delivery.

Authors:  N B Kyrklund-Blomberg; S Cnattingius
Journal:  Am J Obstet Gynecol       Date:  1998-10       Impact factor: 8.661

3.  Fetal and maternal contributions to risk of pre-eclampsia: population based study.

Authors:  R T Lie; S Rasmussen; H Brunborg; H K Gjessing; E Lie-Nielsen; L M Irgens
Journal:  BMJ       Date:  1998-05-02

4.  Changing paternity and the risk of preeclampsia/eclampsia in the subsequent pregnancy.

Authors:  D K Li; S Wi
Journal:  Am J Epidemiol       Date:  2000-01-01       Impact factor: 4.897

Review 5.  Preeclampsia and breast cancer risk.

Authors:  K E Innes; T E Byers
Journal:  Epidemiology       Date:  1999-11       Impact factor: 4.822

6.  Preeclampsia and genetic risk factors for thrombosis: a case-control study.

Authors:  C J De Groot; K W Bloemenkamp; E J Duvekot; F M Helmerhorst; R M Bertina; F Van Der Meer; H De Ronde; S G Oei; H H Kanhai; F R Rosendaal
Journal:  Am J Obstet Gynecol       Date:  1999-10       Impact factor: 8.661

7.  The paradoxical effect of smoking in preeclamptic pregnancies: smoking reduces the incidence but increases the rates of perinatal mortality, abruptio placentae, and intrauterine growth restriction.

Authors:  S Cnattingius; J L Mills; J Yuen; O Eriksson; H Salonen
Journal:  Am J Obstet Gynecol       Date:  1997-07       Impact factor: 8.661

8.  Increased frequency of genetic thrombophilia in women with complications of pregnancy.

Authors:  M J Kupferminc; A Eldor; N Steinman; A Many; A Bar-Am; A Jaffa; G Fait; J B Lessing
Journal:  N Engl J Med       Date:  1999-01-07       Impact factor: 91.245

9.  Breast cancer incidence before age 55 in relation to parity and age at first and last births: a prospective study of one million Norwegian women.

Authors:  G Albrektsen; I Heuch; S Tretli; G Kvåle
Journal:  Epidemiology       Date:  1994-11       Impact factor: 4.822

10.  Multiple births, sex of children and subsequent breast-cancer risk for the mothers: a prospective study in Norway.

Authors:  G Albrektsen; I Heuch; G Kvåle
Journal:  Int J Cancer       Date:  1995-01-27       Impact factor: 7.396

View more
  240 in total

1.  IL-6-induced pathophysiology during pre-eclampsia: potential therapeutic role for magnesium sulfate?

Authors:  Babbette Lamarca; Justin Brewer; Kedra Wallace
Journal:  Int J Interferon Cytokine Mediat Res       Date:  2011-07-01

2.  Lamashtu, "she who erases", touched her stomach seven times to kill the child.

Authors:  F R W van de Goot; R L ten Berge
Journal:  J Clin Pathol       Date:  2002-07       Impact factor: 3.411

3.  Pre-eclampsia and the risk of cancer.

Authors:  Aliki Taylor
Journal:  BMJ       Date:  2004-04-17

4.  Prepregnancy lipids related to preterm birth risk: the coronary artery risk development in young adults study.

Authors:  Janet M Catov; Roberta B Ness; Melissa F Wellons; David R Jacobs; James M Roberts; Erica P Gunderson
Journal:  J Clin Endocrinol Metab       Date:  2010-05-25       Impact factor: 5.958

5.  The role of immune activation in contributing to vascular dysfunction and the pathophysiology of hypertension during preeclampsia.

Authors:  B Lamarca
Journal:  Minerva Ginecol       Date:  2010-04

Review 6.  Molecular Mechanisms of Preeclampsia.

Authors:  Tammy Hod; Ana Sofia Cerdeira; S Ananth Karumanchi
Journal:  Cold Spring Harb Perspect Med       Date:  2015-08-20       Impact factor: 6.915

7.  The two stage model of preeclampsia: variations on the theme.

Authors:  J M Roberts; C A Hubel
Journal:  Placenta       Date:  2008-12-13       Impact factor: 3.481

8.  Hypertensive Disorders of Pregnancy - A Life-Long Risk?!

Authors:  C E Schausberger; V R Jacobs; G Bogner; P Wolfrum-Ristau; T Fischer
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-01       Impact factor: 2.915

9.  Increased plasma norepinephrine levels in previously pre-eclamptic women.

Authors:  K H Lampinen; M Rönnback; P-H Groop; M G Nicholls; T G Yandle; R J Kaaja
Journal:  J Hum Hypertens       Date:  2013-09-19       Impact factor: 3.012

10.  Diagnosis and Treatment of Hypertensive Pregnancy Disorders. Guideline of DGGG (S1-Level, AWMF Registry No. 015/018, December 2013).

Authors:  H Stepan; S Kuse-Föhl; W Klockenbusch; W Rath; B Schauf; T Walther; D Schlembach
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-09       Impact factor: 2.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.